Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetes

Cohort profile: the German Diabetes Study (GDS)

(2016) Julia Szendroedi et al.   Cardiovascular Diabetology

Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes

(2016) Imke Schamarek et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Inflammatory markers are associated with cardiac autonomic dysfunction in recent-onset type 2 diabetes

(2016) Christian Herder et al.   HEART

Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects — (CURES-133)

(2015) R. Pradeepa et al.   CLINICAL BIOCHEMISTRY

The Role of Markers of Low-Grade Inflammation for the Early Time Course of Glycemic Control, Glucose Disappearance Rate, and β-Cell Function in Recently Diagnosed Type 1 and Type 2 Diabetes

(2015) Katharina S. Weber et al.   DIABETES CARE

Adiponectin, cardiovascular disease, and mortality: Parsing the dual prognostic implications of a complex adipokine

(2014) Jorge R. Kizer   METABOLISM-CLINICAL AND EXPERIMENTAL

Circulating adiponectin levels and risk of type 2 diabetes in the Japanese

(2014) S Yamamoto et al.   Nutrition & Diabetes

Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetic Patients With or Without Renal Dysfunction: Results from the ESTHER study

(2013) B. Schottker et al.   DIABETES CARE

Anti-inflammatory cytokines and risk of type 2 diabetes

(2013) C. Herder et al.   DIABETES OBESITY & METABOLISM

Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus

(2013) Chan-Hee Jung et al.   Journal of Diabetes Investigation

Serum Adiponectin in Relation to Race–Ethnicity and Vascular Risk Factors in the Northern Manhattan Study

(2012) Hannah Gardener et al.   Metabolic Syndrome and Related Disorders

Adiponectin and raised mortality in type 1 diabetes: any credible explanatory mechanisms?*

(2011) N. Sattar   JOURNAL OF INTERNAL MEDICINE

Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes

(2011) C. Forsblom et al.   JOURNAL OF INTERNAL MEDICINE

Hypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?

(2010) Joshua R. Cook et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics

(2009) A. Tura et al.   DIABETOLOGIA

Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes

(2008) M. Saraheimo et al.   DIABETES CARE

Elevated Levels of High-Molecular-Weight Adiponectin in Type 1 Diabetes

(2008) Henrik Leth et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM